FEB 02, 2016 07:13 AM PST

First License to Genetically Edit Human Embryos Granted

Embryonic development from single cell (top left) to blastocyst (bottom right).

In a historic, unprecedented move, UK national fertility regulators have given the green light for scientists to use the new CRISPR-cas9 gene-editing tool to manipulate human embryos. The approval stirred up big waves amongst the scientific community, as many leading nations are still observing a voluntarily moratorium to halt gene-editing in human embryonic cells.
Kathy NiakanThe research application, which was approved by the Human Fertilization and Embryology Authority (HFEA), outlined the use of CRISPR-cas9 to study how human embryonic development happens. Dr. Kathy Niakan leads this research endeavor. She explained that her research could help scientists better understand fertility and possibility solve infertility. 

We would really like to understand the genes needed for a human embryo to develop successfully into a healthy baby. The reason why it is so important is because miscarriages and infertility are extremely common, but they're not very well understood. – Dr. Niakan

There’s one major stipulation of the approval: the scientists cannot implant the edited embryos into any wombs, not that Dr. Niakan was planning to anyways. Her research will focus on the genetic changes in the embryos in the first several days of development. After seven days, the experiments will stop and the embryos will be destroyed.
This clause clearly stems from scientists’ uncertainties over the consequences of modifying human germ cells and early embryos. Unlike conventional gene therapies that target other cells in the body, gene editing in germ cells (sperm and egg) or early embryos has the potential to affect the genetics of future generations. That means genetic alterations could be passed on to children and even grandchildren. Because of the relative low cost and high efficiency of CRISPR/Cas9, gene manipulation in these precarious cells has never been easier. And this makes many people quite uneasy.
Some people applaud the landmark approval, noting that the decision struck a balance between scientific progress and ethical considerations.

Dr Niakan's proposed research is important for understanding how a healthy human embryo develops and will enhance our understanding of IVF success rates, by looking at the very earliest stage of human development. – Paul Nurse, the director of the Crick Institue.

"This decision is a victory for level-headed regulation over moral panic," added Sarah Norcross, director of the Progress Educational Trust.

Still, some think we may be dangerously close to crossing the line of unethical genetic manipulations.

So this is the first step in a well mapped-out process leading to GM babies, and a future of consumer eugenics. – Dr. David King, the director of Human Genetics Alert

How do you, readers, weigh in?

Sources: Nature News, New York Times, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 20, 2018
Clinical & Molecular DX
APR 20, 2018
One Concussion Raises the Risk of Parkinson's Disease
A diagnosis of a mild concussion or a traumatic brain injury (TBI) raises the risk of developing Parkinson’s disease, according to a new study from t...
MAY 14, 2018
MAY 14, 2018
What Is Computational Oncology?
Computational Oncology is an emerging field of science and medicine aimed at using mathematical and computer modeling systems to organize tumor marker profiles and hone precision medicine....
MAY 23, 2018
Clinical & Molecular DX
MAY 23, 2018
Rapidly Screening Genes in 'Living Test Tubes'
Diagnosing rare disorders is often extremely challenging. Now scientists have developed a new tool for that purpose....
JUN 02, 2018
JUN 02, 2018
New Test Predicts Lupus Onset
Based on several different factors, scientists have a new risk index for predicting who will develop lupus. From the Feinstein Institute for Medical Resear...
JUL 02, 2018
JUL 02, 2018
AF Treatment Zaps Faulty Heart Tissue
Treating atrial fibrillation (AF), the most common type of arrhythmia, with what was previously a last-resort therapeutic approach will help reduce the ris...
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Nanotech patch makes light-up medical tests 100x brighter
Researchers have developed a high-tech fix that uses metal nanostructures to increase the fluorescence intensity by 100 times in diagnostic tests. It&rsquo...
Loading Comments...